Aberrant PI3K signaling is critical in driving tumor initiation and progression through the dysregulation of several cellular processes, such as proliferation, growth, apoptosis, survival, and cytoskeletal rearrangement, in many cancers, including CRC [9,10,11]. This evidence concerns the gene PIK3CB and cancer.